Kasuwar maganin salula ta duniya darajar ta kasance Dalar Amurka biliyan 10.23 a cikin 2021. Wannan zai ci gaba da girma a CAGR na 13.3% sama da lokacin hasashen 2023-2032.
Maganin kwayar halitta fasaha ce da ke maye gurbin sel masu lalacewa ko rashin aiki tare da sel masu aiki lafiya. Domin sel masu tushe na iya bambanta cikin sel da ake buƙata don gyara sel ko nama da suka lalace, su ne ƙwayoyin da aka fi amfani da su a cikin manyan hanyoyin warkewa. Maganin farfadowa wani yanki ne da za a iya amfani da maganin tantanin halitta. Ya ƙunshi ƙirƙirar magunguna da yawa waɗanda ke da nufin kiyayewa, haɓakawa ko dawo da aikin tantanin halitta, nama, ko gabobin jiki. A cikin maganin tantanin halitta, ana amfani da sel da yawa, ciki har da jini, ƙwayoyin kasusuwan kasusuwa, sel balagagge da waɗanda ba su balaga ba, babban tushe, da ƙwayoyin amfrayo, ana amfani da su. Bugu da ƙari, ƙwayoyin da aka dasa, ciki har da ƙwararrun sel masu ƙarfi (iPSCs), ƙwayoyin embryonic da na jijiyoyi (NSCs), da kuma mesenchymal da sel mesenchymal (MSCs), ana iya raba su zuwa manyan ƙungiyoyi biyu: autologous da waɗanda ba masu sarrafa kansu ba.
Buƙatar Samfuran Kwafin Kasuwar Magungunan Kwayoyin cuta tare da Cikakken TOC da Figures & Graphs@ https://market.us/report/cell-therapy-market/request-sample
Kasuwar maganin salula: Direbobi
Yunƙurin bincike na tushen tantanin halitta da kudade ya samo asali daga buƙatar sabbin, ingantattun magunguna don yanayi kamar kansa da CVD. Gwamnatin Ostiraliya ta buga Ofishin Jakadancin Stem Cell Therapies a watan Nuwamba 2019. Dabarar shekaru 10 ce da za ta tallafa wa binciken ƙwayar ƙwayar cuta a cikin Ostiraliya. Asusun Bincike na Lafiya na nan gaba zai ba da kuɗin aikin tare da dala miliyan 102 (AU $ 150million) don tallafawa binciken ƙwayar ƙwayar cuta da haɓaka sabbin magunguna. An ba Innovate UK (Hukumar kirkire-kirkire ta Burtaniya) dalar Amurka 269670 (GBP 267,000) a cikin Satumba 2019 don ba da gudummawar haɓaka fasahohin tabbatar da gel. Wannan ya kasance a matsayin martani ga burin farko na Atelerix na haɓaka rayuwar rayuwar Rexgenero na tushen jiyya waɗanda za'a iya adanawa da jigilar su cikin zafin jiki.
Cell far Kasuwa: takurawa
Duk da ci gaban fasaha da ci gaban samfur a cikin shekaru goma da suka gabata, masana'antar ta sami cikas sakamakon ƙarancin ƙwararrun ƙwararrun ma'aikata don sarrafa na'urori masu rikitarwa kamar masu karanta yanayi da yawa da na'urori masu gudana. Na'urori masu ƙarfin fasaha irin su spectrophotometers da cytometers masu gudana suna iya samar da bayanan da yawa waɗanda ke buƙatar ƙwararrun bincike da bita. A cewar Hukumar Ba da Lamuni ta Ƙasa don Kimiyyar Laboratory Clinical, akwai ƙarancin ƙwararrun mutane a duniya (NAACLS). A cikin shekaru goma masu zuwa, Turai da Burtaniya za su iya fuskantar matsanancin ƙarancin ƙarfin dakin gwaje-gwaje. Dakunan gwaje-gwajen likitancin Burtaniya ne za su fi fama da cutar.
Wani Tambaya?
Nemi Anan don Gyara Rahoton: https://market.us/report/cell-therapy-market/#inquiry
Cell far Mabuɗin Kasuwanci:
Ana sa ran Raba Kasuwa zai zama mahimmanci ga Sashin Allogeneic Therapies Therapy
Magungunan Allogeneic sun dogara ga tushen sel guda ɗaya don kula da marasa lafiya da yawa. Suna iya haifar da amsawar rigakafi a cikin marasa lafiya kuma galibi ana haɗa su tare da jiyya na rigakafi. Wannan shine dalilin da ya sa likitoci suna ƙara sha'awar yin amfani da allogeneic therapeutically. Hakanan ana samun wayewar kai game da yuwuwar warkewar ƙwayoyin igiya da sauran kyallen takarda a wurare daban-daban na jiyya. Amfanin ƙwayoyin allogenic shine cewa suna samar da ƙwayoyin rigakafi na rigakafi waɗanda ke kashe duk sauran ƙwayoyin cutar kansa ko da bayan babban adadin chemotherapy tare da magungunan cytotoxic. Wannan shi ake kira da graft-versus–ciwon daji. Ana amfani da shi don rigakafin komowar kansa da magani. A cikin lokacin hasashen, abubuwan da aka ambata a sama zasu jagoranci kasuwar.
Ana sa ran ɓangaren zai yi girma saboda karuwar yawan gwaje-gwajen asibiti da ake buƙata don samun amincewar tsari don sababbin magunguna. Sashin yana da damar haɓaka da yawa, kamar ALLO-501, Allo-501A, da ALLO-715.
Bugu da ƙari, Allogene Therapeutics Inc. & SpringWorks Therapeutics Inc. sun shiga yarjejeniyar haɗin gwiwar asibiti don kimantawa da kuma kula da ALLO-715 a cikin marasa lafiya na myeloma da yawa.
Wannan shi ne saboda karuwar yawan binciken bincike game da maganin allogenic don maganin ciwon daji da kuma abubuwan da ke tattare da shi. Lokacin hasashen zai ga tsayayyen girma.
Ci gaban kwanan nan:
Hukumar Abinci da Magunguna (KIMMTRAK) ta amince da Immunocore a cikin Janairu 2022 don magance melanoma mai ƙazantawa ko mara lahani.
Hukumar Abinci da Magunguna ta amince da Novadip Biosciences a cikin Maris 2021 don sake haifuwa samfurin kashi NVD003 don magance cututtukan ƙashi da ba kasafai ba.
Yankin Rahoton
| sifa | details |
| Girman Kasuwa a 2021 | Dalar Amurka biliyan 10.23 |
| Matsakaicin Girma | CAGR na 13.3% |
| Shekaru masu Tarihi | 2016-2020 |
| Shekarar Base | 2021 |
| Ƙididdigar Raka'a | USD a Bn |
| No. na Shafukan cikin Rahoton | Shafuka 200+ |
| Lambar Tables & Figures | 150 + |
| format | PDF/Excel |
| Kai tsaye oda Wannan Rahoton | Akwai- Don Siyan Wannan Babban Rahoton Danna Nan |
'Yan Wasan Kasuwanci
- Kolon TissueGene Inc. girma
- PHARMICELL Co.,Ltd
- Anterogen Co., Ltd. girma
- Osiris Therapeutics Inc.
- Abubuwan da aka bayar na JCR Pharmaceuticals Co., Ltd.
- Kamfanin Vericel
- Abubuwan da aka bayar na Castle Creek Biosciences Inc.
- Kamfanin Celgene
- Kamfanin Danaher
- NuVasive, Inc. girma
- smith & dan uwa
- Abubuwan da aka bayar na Osiris Therapeutics, Inc
- Abubuwan da aka bayar na Tameika Cell Technologies, Inc.
- Sauran manyan 'yan wasa
Ta Amfani-Nau'in
- Bincike-amfani
- Clinical-amfani
By Therapy Type
- Magungunan Kwayoyin cuta
- Allogenic Therapies
Masana'antu, Ta Yanki
- Asiya-Pacific [China, Kudu maso Gabashin Asiya, Indiya, Japan, Koriya, Yammacin Asiya]
- Turai [Jamus, UK, Faransa, Italiya, Rasha, Spain, Netherlands, Turkey, Switzerland]
- Arewacin Amurka [Amurka, Kanada, Mexico]
- Gabas ta Tsakiya & Afirka [GCC, Arewacin Afirka, Afirka ta Kudu]
- Kudancin Amirka [Brazil, Argentina, Columbia, Chile, Peru]
Tambayoyi masu mahimmanci:
- Menene CAGR don kasuwar maganin ƙwayar cuta ta duniya a cikin 2019?
- Wanene babban ɗan wasa a kasuwar maganin tantanin halitta, kuma me ya sa?
- Menene abubuwan motsa jiki na maganin tantanin halitta?
- Wane yanki ne zai zama jagora a maganin tantanin halitta?
- Menene manyan abubuwan da ke faruwa a kasuwar maganin tantanin halitta?
- Menene girma% da darajar kasuwa na ƙasashe masu tasowa?
- Wane yanki ne ke da kaso mafi girma na Kasuwar Therapy?
Ƙarin Rahotanni masu dangantaka daga Shafin Market.us:
The Kasuwar kayan aikin lura da ƙwayoyin cuta ta duniya ana hasashen zai kai ga kimantawa Dalar Amurka 4.29 da 2032 a CAGR of 5.0%, daga Dalar Amurka 2.63 a 2022.
A 2021, da kasuwar al'adun kwayar halitta ta duniya lissafi USD Biliyan 38.58. An keɓe shi don yin rijistar CAGR na 13% tsakanin 2023 zuwa 2032.
Kasuwa ta duniya don 3D cell al'ada ya cancanci USD Biliyan 1.65 a cikin 2021. Ana sa ran wannan kasuwa zai yi girma a wani 9.8% CAGR.
The Kasuwar Al'adun Salula Mai sarrafa kansa ana hasashen zai kai ga kimantawa dalar Amurka miliyan 526.22 ta 2032 a CAGR na 7.9%, daga USD 228 Mn a 2021.
A duniya Single-Cell Multiomics Маrkеt an tsara zai kai Dalar Amurka 18.36 da 2031 a CAGR na 21.40%, daga Dalar Amurka 2.64 a 2021.
Kasuwar Watsa Labarai ta Al'adu Ana tsammanin yayi girma a CAGR na kusan 7.8% a cikin shekaru goma masu zuwa, kuma zai kai dala biliyan 1.59 a shekarar 2028, daga dala biliyan 0.7533 a shekarar 2018
The Duniya mesotherapy injector gun kasuwar a ranar 206.8 ya kasance 2020 US dollar
328.7 miliyan ta 2030 a CAGR na 4.8%.
Game da Kasuwa.us
Market.US (Powered by Prudour Private Limited) ƙwararre ne a cikin zurfin bincike da bincike na kasuwa kuma yana tabbatar da ƙarfinsa a matsayin mai ba da shawara da kamfanin bincike na kasuwa na musamman, baya ga kasancewar rahoton bincike na kasuwa da ake nema da yawa wanda ke samar da kamfani.
Bayanan hulda:
Ƙungiyar Ci gaban Kasuwancin Duniya - Market.us
Adireshin: 420 Lexington Avenue, Suite 300 New York City, NY 10170, Amurka
Waya: +1 718 618 4351 (International), Waya: +91 78878 22626 (Asiya)
email: [email kariya]
